Literature DB >> 10650740

Multi-state models in epidemiology.

D Commenges1.   

Abstract

I first discuss the main assumptions which can be made for multi-state models: the time-homogeneity and semi-Markov assumptions, the problem of choice of the time scale, the assumption of homogeneity of the population and also assumptions about the way the observations are incomplete, leading to truncation and censoring. The influence of covariates and different durations and time-dependent variables are synthesized using explanatory processes, and a general additive model for transition intensities presented. Different inference approaches, including penalized likelihood, are considered. Finally three examples of application in epidemiology are presented and some references to other works are given.

Mesh:

Year:  1999        PMID: 10650740     DOI: 10.1023/a:1009636125294

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  18 in total

Review 1.  Multi-state models: a review.

Authors:  P Hougaard
Journal:  Lifetime Data Anal       Date:  1999-09       Impact factor: 1.588

2.  A penalized likelihood approach for a progressive three-state model with censored and truncated data: application to AIDS.

Authors:  P Joly; D Commenges
Journal:  Biometrics       Date:  1999-09       Impact factor: 2.571

3.  Multi-state models and diabetic retinopathy.

Authors:  G Marshall; R H Jones
Journal:  Stat Med       Date:  1995-09-30       Impact factor: 2.373

4.  Analysis of doubly-censored survival data, with application to AIDS.

Authors:  V De Gruttola; S W Lagakos
Journal:  Biometrics       Date:  1989-03       Impact factor: 2.571

5.  Multistate survival analysis: an application in breast cancer.

Authors:  R Kay
Journal:  Methods Inf Med       Date:  1984-07       Impact factor: 2.176

6.  Estimation of prolongation of hospital stay attributable to nosocomial infections: new approaches based on multistate models.

Authors:  G Schulgen; M Schumacher
Journal:  Lifetime Data Anal       Date:  1996       Impact factor: 1.588

7.  Effect of gender, age, transmission category, and antiretroviral therapy on the progression of human immunodeficiency virus infection using multistate Markov models. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.

Authors:  A Alioum; V Leroy; D Commenges; F Dabis; R Salamon
Journal:  Epidemiology       Date:  1998-11       Impact factor: 4.822

8.  Modelling age-specific risk: application to dementia.

Authors:  D Commenges; L Letenneur; P Joly; A Alioum; J F Dartigues
Journal:  Stat Med       Date:  1998-09-15       Impact factor: 2.373

9.  Statistical analysis of the stages of HIV infection using a Markov model.

Authors:  I M Longini; W S Clark; R H Byers; J W Ward; W W Darrow; G F Lemp; H W Hethcote
Journal:  Stat Med       Date:  1989-07       Impact factor: 2.373

10.  Plotting summary predictions in multistate survival models: probabilities of relapse and death in remission for bone marrow transplantation patients.

Authors:  J P Klein; N Keiding; E A Copelan
Journal:  Stat Med       Date:  1993-12-30       Impact factor: 2.373

View more
  34 in total

1.  Nonparametric estimation of transition probabilities in a non-Markov illness-death model.

Authors:  Luís Meira-Machado; Jacobo de Uña-Alvarez; Carmen Cadarso-Suárez
Journal:  Lifetime Data Anal       Date:  2006-08-18       Impact factor: 1.588

Review 2.  Inference for outcome probabilities in multi-state models.

Authors:  Per Kragh Andersen; Maja Pohar Perme
Journal:  Lifetime Data Anal       Date:  2008-09-13       Impact factor: 1.588

3.  The multistate life table method: an application to contraceptive switching behavior.

Authors:  Tzy-Mey Kuo; C M Suchindran; Helen P Koo
Journal:  Demography       Date:  2008-02

4.  Boosting multi-state models.

Authors:  Holger Reulen; Thomas Kneib
Journal:  Lifetime Data Anal       Date:  2015-05-20       Impact factor: 1.588

5.  Measuring concurrency using a joint multistate and point process model for retrospective sexual history data.

Authors:  Hilary J Aralis; Pamina M Gorbach; Ron Brookmeyer
Journal:  Stat Med       Date:  2016-06-20       Impact factor: 2.373

6.  A comparison of time-homogeneous Markov chain and Markov process multi-state models.

Authors:  Lijie Wan; Wenjie Lou; Erin Abner; Richard J Kryscio
Journal:  Commun Stat Case Stud Data Anal Appl       Date:  2017-08-18

7.  Application of multi-state models in cancer clinical trials.

Authors:  Jennifer G Le-Rademacher; Ryan A Peterson; Terry M Therneau; Ben L Sanford; Richard M Stone; Sumithra J Mandrekar
Journal:  Clin Trials       Date:  2018-07-23       Impact factor: 2.486

8.  Bayesian path specific frailty models for multi-state survival data with applications.

Authors:  Mário de Castro; Ming-Hui Chen; Yuanye Zhang
Journal:  Biometrics       Date:  2015-03-11       Impact factor: 2.571

9.  Multi-state models for the analysis of time-to-event data.

Authors:  Luís Meira-Machado; Jacobo de Uña-Alvarez; Carmen Cadarso-Suárez; Per K Andersen
Journal:  Stat Methods Med Res       Date:  2008-06-18       Impact factor: 3.021

10.  Estimating stroke-free and total life expectancy in the presence of non-ignorable missing values.

Authors:  Ardo van den Hout; Fiona E Matthews
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2010-04       Impact factor: 2.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.